Page last updated: 2024-10-15

gardimycin

Description

gardimycin: a globular type B lantibiotic; from actinoplanes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16132310
MeSH IDM0060414

Synonyms (8)

Synonym
actagardine
gardimycin
actagardinum
antibiotic a 3802-iv-3
actagardina
59165-34-3
DTXSID80207893
Q15633940

Pharmacokinetics

ExcerptReference
" Researches have encouraged clinical evaluation of a few compounds, such as mutacin 1140, microbisporicin, actagardine and duramycin, with pharmacokinetic profiles showing rapid distribution and elimination rates, good bioavailability and fecal excretion, as well as high protein binding."( Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies.
Neubauer, P; Ongey, EL; Pflugmacher, S; Yassi, H, 2017
)

Bioavailability

ExcerptReference
" Researches have encouraged clinical evaluation of a few compounds, such as mutacin 1140, microbisporicin, actagardine and duramycin, with pharmacokinetic profiles showing rapid distribution and elimination rates, good bioavailability and fecal excretion, as well as high protein binding."( Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies.
Neubauer, P; Ongey, EL; Pflugmacher, S; Yassi, H, 2017
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's6 (37.50)18.2507
2000's3 (18.75)29.6817
2010's6 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]